Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

June 14, 2017

Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa

June 13, 2017

First patient enrolled in DELIVERS trial of Castle Creek Pharmaceuticals' CCP-020

June 6, 2017

FDA grants rare pediatric disease designation to Amicus' SD-101 for epidermolysis bullosa

June 1, 2017

FDA gives rare pediatric disease designation to EB-101 from Abeona

May 31, 2017

FDA awards orphan drug designation to EB-101 from Abeona Therapeutics

May 26, 2017

EMA committee gives positive opinion to brodalumab for plaque psoriasis

May 23, 2017

FDA places CTP-543 phase IIa study on hold

May 18, 2017

Board recommends continuation of Fibrocell Science's phase I/II study of FCX-007

May 9, 2017

BioPharmX's phase IIb study of BPX-011 in acne meets primary endpoint

May 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...